DK1060187T3 - S-substituerede 11beta-benzaldoxim-estra-4,9-dien-carboxylsyrethiolestere, fremgangsmåde til deres fremstilling og farmaceutiske tilberedninger indeholdende disse forbindelser - Google Patents

S-substituerede 11beta-benzaldoxim-estra-4,9-dien-carboxylsyrethiolestere, fremgangsmåde til deres fremstilling og farmaceutiske tilberedninger indeholdende disse forbindelser

Info

Publication number
DK1060187T3
DK1060187T3 DK99915475T DK99915475T DK1060187T3 DK 1060187 T3 DK1060187 T3 DK 1060187T3 DK 99915475 T DK99915475 T DK 99915475T DK 99915475 T DK99915475 T DK 99915475T DK 1060187 T3 DK1060187 T3 DK 1060187T3
Authority
DK
Denmark
Prior art keywords
compounds
benzaldoxime
11beta
estra
substituted
Prior art date
Application number
DK99915475T
Other languages
Danish (da)
English (en)
Inventor
Gerd Schubert
Sven Ring
Guenther Kaufmann
Walter Elger
Birgit Schneider
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK1060187T3 publication Critical patent/DK1060187T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK99915475T 1998-03-03 1999-02-10 S-substituerede 11beta-benzaldoxim-estra-4,9-dien-carboxylsyrethiolestere, fremgangsmåde til deres fremstilling og farmaceutiske tilberedninger indeholdende disse forbindelser DK1060187T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19809845A DE19809845A1 (de) 1998-03-03 1998-03-03 S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
PCT/DE1999/000408 WO1999045023A1 (de) 1998-03-03 1999-02-10 S-SUBSTITUIERTE 11β-BENZALDOXIM-ESTRA-4,9-DIEN-KOHLENSÄURETHIOLESTER, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENE PHARMAZEUTISCHE ZUBEREITUNGEN

Publications (1)

Publication Number Publication Date
DK1060187T3 true DK1060187T3 (da) 2003-08-11

Family

ID=7860080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99915475T DK1060187T3 (da) 1998-03-03 1999-02-10 S-substituerede 11beta-benzaldoxim-estra-4,9-dien-carboxylsyrethiolestere, fremgangsmåde til deres fremstilling og farmaceutiske tilberedninger indeholdende disse forbindelser

Country Status (28)

Country Link
US (1) US6365582B1 (bg)
EP (1) EP1060187B1 (bg)
JP (1) JP3796405B2 (bg)
KR (1) KR100488823B1 (bg)
CN (1) CN1208341C (bg)
AT (1) ATE237627T1 (bg)
AU (1) AU749163B2 (bg)
BG (1) BG64735B1 (bg)
BR (1) BR9908458A (bg)
CA (1) CA2322471C (bg)
CZ (1) CZ20003125A3 (bg)
DE (2) DE19809845A1 (bg)
DK (1) DK1060187T3 (bg)
EA (1) EA002766B1 (bg)
EE (1) EE04242B1 (bg)
ES (1) ES2197634T3 (bg)
HU (1) HUP0100962A3 (bg)
ID (1) ID26972A (bg)
IL (1) IL137851A (bg)
IS (1) IS5579A (bg)
NO (1) NO316977B1 (bg)
NZ (1) NZ506048A (bg)
PL (1) PL193687B1 (bg)
PT (1) PT1060187E (bg)
SK (1) SK284177B6 (bg)
TR (1) TR200002506T2 (bg)
UA (1) UA59437C2 (bg)
WO (1) WO1999045023A1 (bg)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
CO5190694A1 (es) * 1999-08-31 2002-08-29 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores de progesterona) como componentes de anticonceptivos femeninos
US7629334B1 (en) * 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
CA2383659C (en) * 1999-08-31 2009-02-10 Jenapharm Gmbh & Co. Kg Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
US8193252B1 (en) 1999-08-31 2012-06-05 Bayer Pharma AG Mesoprogestins (progesterone receptor modulators) for the treatment and prevention of benign hormone dependent gynecological disorders
RO122179B1 (ro) * 1999-08-31 2009-02-27 Schering Aktiengesellschaft Utilizarea de mezoprogestine pentru tratamentul şi prevenirea afecţiunilor ginecologice benigne, hormon-dependente
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10221034A1 (de) * 2002-05-03 2003-11-20 Schering Ag 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
DE10236405A1 (de) * 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
ES2273061T3 (es) * 2002-08-02 2007-05-01 Schering Aktiengesellschaft Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal.
DE102005059222B4 (de) * 2005-12-08 2007-10-11 Bayer Schering Pharma Ag 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen
CA2673128C (en) 2006-10-24 2018-07-03 Repros Therapeutics Inc. Compositions and methods for suppressing endometrial proliferation
CA2680119A1 (en) * 2007-03-07 2008-09-12 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
DE102009034525A1 (de) * 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
CN102906103A (zh) 2010-03-22 2013-01-30 利普生物药剂公司 用于抗孕酮的非毒性递送的组合物和方法
EP2664325A1 (en) * 2012-05-16 2013-11-20 PregLem S.A. Methods for preventing or treating androgen mediated diseases

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039677A (en) * 1976-03-01 1977-08-02 Syntex (U.S.A.) Inc. Novel 1-phenethylimidazoles
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
DE3504421A1 (de) * 1985-02-07 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284C2 (de) * 1993-09-20 1997-05-28 Jenapharm Gmbh 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
JPH10507461A (ja) * 1994-10-24 1998-07-21 シエーリング アクチエンゲゼルシヤフト 必要に応じて女性の稔性を調節するための競合的プロゲステロン拮抗物質
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
UA57703C2 (uk) * 1995-03-14 2003-07-15 Шерінг Актієнгезеллшафт Спосіб стимуляції та спосіб інгібування дозрівання шийки матки

Also Published As

Publication number Publication date
JP3796405B2 (ja) 2006-07-12
NZ506048A (en) 2003-05-30
HUP0100962A3 (en) 2002-07-29
NO20004362L (no) 2000-10-31
KR100488823B1 (ko) 2005-05-12
NO316977B1 (no) 2004-07-12
DE59905075D1 (de) 2003-05-22
EE200000500A (et) 2002-02-15
NO20004362D0 (no) 2000-09-01
ES2197634T3 (es) 2004-01-01
JP2002505335A (ja) 2002-02-19
CN1291990A (zh) 2001-04-18
UA59437C2 (uk) 2003-09-15
BG104712A (bg) 2001-02-28
IS5579A (is) 2000-07-28
IL137851A (en) 2005-06-19
EP1060187A1 (de) 2000-12-20
CA2322471C (en) 2007-04-24
BG64735B1 (bg) 2006-01-31
EA002766B1 (ru) 2002-08-29
US6365582B1 (en) 2002-04-02
EE04242B1 (et) 2004-02-16
PL193687B1 (pl) 2007-03-30
CN1208341C (zh) 2005-06-29
HUP0100962A2 (hu) 2001-09-28
CZ20003125A3 (cs) 2002-01-16
WO1999045023A1 (de) 1999-09-10
SK13052000A3 (sk) 2001-11-06
DE19809845A1 (de) 1999-09-09
CA2322471A1 (en) 1999-09-10
BR9908458A (pt) 2000-11-14
SK284177B6 (sk) 2004-10-05
KR20010041536A (ko) 2001-05-25
ATE237627T1 (de) 2003-05-15
PL342449A1 (en) 2001-06-04
AU749163B2 (en) 2002-06-20
EP1060187B1 (de) 2003-04-16
PT1060187E (pt) 2003-09-30
AU3406799A (en) 1999-09-20
ID26972A (id) 2001-02-22
IL137851A0 (en) 2001-10-31
EA200000896A1 (ru) 2001-04-23
TR200002506T2 (tr) 2000-12-21

Similar Documents

Publication Publication Date Title
DK1060187T3 (da) S-substituerede 11beta-benzaldoxim-estra-4,9-dien-carboxylsyrethiolestere, fremgangsmåde til deres fremstilling og farmaceutiske tilberedninger indeholdende disse forbindelser
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
NO20005431D0 (no) Gelérbare farmasøytiske preparater
CY1107438T1 (el) Παραγωγα καρβοξυλικου οξεος, τα οποια παρεμποδιζουν την συνδεσιν ιντεγκρινων εις τους υποδοχεις των
FI973733A0 (fi) Farmaceutiskt preparat och foerfarande foer dess framstaellning
ES499870A0 (es) Un procedimiento para la preparacion de derivados de indano
BG106389A (bg) Кристали на натриевата сол на правастатин
ATE404211T1 (de) Xenon als nmda-antogonist zur neuroprotektion
DE60014369D1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
DE3481419D1 (de) Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten.
UA35607C2 (uk) Похідні оксазолідинонкарбонової кислоти, спосіб їх одержання, фармацевтична композиція і спосіб її одержання
BG104981A (bg) Заместени бета - аминокиселинни инхибитори на метионин аминопептидаза - 2
BR0112558A (pt) Composto, isÈmero de um composto, composição farmacêutica, método para o tratamento ou profilaxia de doenças ou condições que envolvem o dano ao tecido, e, uso de um composto
DK1090028T3 (da) Umættede 14,15-cyclopropano-androstaner, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende disse forbindelser
YU74401A (sh) Postupak za dobijanje 2s-3-amino-3-arilpropionske kiseline i njenih derivata
JPH0769883A (ja) アロマターゼ阻害剤
HUT54039A (en) Process for producing galenic compositions ensuring optimal biological accessibility of 2-hydroxy-5-methyllaurophenoneoxime active ingredient
ECSP951622A (es) Compuestos quimicos
DK1240162T3 (da) 3-imino-1,2-dithiolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
ES465758A1 (es) Procedimiento de obtencion del monoester del acido p-cloro- fenoxi-isobutirico con 2,6-piridindimetanol, nuevo farmaco con accion hipocolesteremiante.
SE9901338D0 (sv) Novel process